Literature DB >> 18817901

Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women.

Mickaël Hiligsmann1, Olivier Bruyère, Olivier Ethgen, Henry-Jean Gathon, Jean-Yves Reginster.   

Abstract

OBJECTIVES: To estimate the lifetime absolute risks of hip and other osteoporotic fracture in Belgian women aged 60 years and to examine the effect of changes in baseline population fracture risk and changes in life expectancy.
MATERIALS AND METHODS: Estimates were performed using a Markov microsimulation model and were based on the incidence of first fracture as well as life expectancy. Baseline scenario included projected mortality rates and increasing fracture incidence by 1% per year. Alternative scenarios were performed on age, life expectancy and trends in fracture incidence. Lifetime fracture risk for osteoporotic population (T-score <or= -2.5) was also estimated.
RESULTS: In the baseline scenario, lifetime absolute risks of hip fracture and of any major osteoporotic fracture (hip, clinical vertebral or wrist) were respectively 24.8% and 44.3%. Alternative scenarios showed that when assuming no change of age-specific fracture rates over time, these lifetime risks were 18.3% and 35.2%, while these values were 20.0% and 38.3% assuming no future mortality reductions. For osteoporotic women, these values were respectively 34.5% and 51.5%.
CONCLUSION: We conclude that absolute lifetime fracture risks are substantial and that trends in fracture incidence and changes in life expectancy have a marked impact on absolute lifetime fracture risks.

Entities:  

Mesh:

Year:  2008        PMID: 18817901     DOI: 10.1016/j.bone.2008.08.119

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

1.  A FRAX® model for the assessment of fracture probability in Belgium.

Authors:  H Johansson; J A Kanis; E V McCloskey; A Odén; J-P Devogelaer; J-M Kaufman; A Neuprez; M Hiligsmann; O Bruyere; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-30       Impact factor: 4.507

2.  The incidence and residual lifetime risk of osteoporosis-related fractures in Korea.

Authors:  Chanmi Park; Yong-Chan Ha; Sunmee Jang; Suhyun Jang; Hyun-Koo Yoon; Young-Kyun Lee
Journal:  J Bone Miner Metab       Date:  2011-06-07       Impact factor: 2.626

3.  Delay from fracture to hospital admission: a new risk factor for hip fracture mortality?

Authors:  E I O Vidal; D C Moreira-Filho; R S Pinheiro; R C Souza; L M Almeida; K R Camargo; P J F Villas Boas; F B Fukushima; C M Coeli
Journal:  Osteoporos Int       Date:  2012-12       Impact factor: 4.507

4.  Cost effectiveness of denosumab compared with oral bisphosphonates in the treatment of post-menopausal osteoporotic women in Belgium.

Authors:  Mickaël Hiligsmann; Jean-Yves Reginster
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

5.  Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.

Authors:  M Hiligsmann; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-04-07       Impact factor: 4.507

6.  MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® Score.

Authors:  A Mugisha; P Bergmann; V Kinnard; L Iconaru; F Baleanu; A Charles; M Surquin; S Rozenberg; F Benoit; J J Body
Journal:  Calcif Tissue Int       Date:  2021-06-23       Impact factor: 4.333

7.  The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromsø, Norway.

Authors:  Luai A Ahmed; Henrik Schirmer; Ashild Bjørnerem; Nina Emaus; Lone Jørgensen; Jan Størmer; Ragnar M Joakimsen
Journal:  Eur J Epidemiol       Date:  2009-05-30       Impact factor: 8.082

8.  Hip fractures in Hefei, China: the Hefei osteoporosis project.

Authors:  Jun Wang; Yin Wang; Wen-Don Liu; Fang Wang; Zong-Sheng Yin
Journal:  J Bone Miner Metab       Date:  2013-06-20       Impact factor: 2.626

9.  Delay in time from fracture to surgery: A potential risk factor for in-hospital mortality in elderly patients with hip fractures.

Authors:  Prannoy Paul; Renjit Thomas Issac
Journal:  J Orthop       Date:  2018-03-13

Review 10.  Health technology assessment in osteoporosis.

Authors:  Mickael Hiligsmann; John A Kanis; Juliet Compston; Cyrus Cooper; Bruno Flamion; Pierre Bergmann; Jean-Jacques Body; Steven Boonen; Olivier Bruyere; Jean-Pierre Devogelaer; Stefan Goemaere; Jean-Marc Kaufman; Serge Rozenberg; Jean-Yves Reginster
Journal:  Calcif Tissue Int       Date:  2013-03-21       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.